의료 관련 주식
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3705 |  AVXL Anavex Life Sciences Corp. - Common Stock | 1.48 USD | -0.67% | -3.90% | -40.32% | -83.37% | 137.19 M USD | ||
| 3707 |  KRRO Korro Bio, Inc. - Common Stock | 9.31 USD | +4.84% | -12.17% | -34.34% | -76.07% | 137.10 M USD | ||
| 3711 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 3.60 USD | +1.69% | -22.58% | -33.21% | +200.00% | 135.85 M USD | ||
| 3712 |  CUE Cue Biopharma, Inc. - Common Stock | 18.67 USD | +0.38% | -15.94% | -46.27% | +2356.58% | 135.63 M USD | ||
| 3713 |  HCAT Health Catalyst, Inc - Common stock | 1.80 USD | +3.45% | +2.27% | 0.00% | -44.44% | 135.46 M USD | ||
| 3723 |  MXCT MaxCyte, Inc. - Common Stock | 1.30 USD | +4.00% | +27.45% | +7.44% | -26.14% | 134.17 M USD | ||
| 3726 |  RNA Atrium Therapeutics, Inc. - Common Stock | 7.82 USD | +1.82% | -5.67% | -18.96% | -88.88% | 133.77 M USD | ||
| 3735 |  OWLT Owlet, Inc. Class A Common Stock | 4.44 USD | +0.45% | -6.53% | -1.55% | -47.64% | 129.74 M USD | ||
| 3744 |  VYGR Voyager Therapeutics, Inc. - Common Stock | 2.06 USD | +2.49% | -12.71% | -32.46% | -55.70% | 126.93 M USD | ||
| 3745 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.05 USD | 0.00% | -7.89% | +23.53% | -46.97% | 126.53 M USD | ||
| 3750 |  OGI Organigram Global Inc. - Common Shares | 0.93 USD | +3.33% | -1.06% | -12.26% | -34.97% | 125.05 M USD | ||
| 3755 |  HUMA Humacyte, Inc. - Common Stock | 0.44 USD | +25.71% | 0.00% | -25.42% | -73.65% | 122.23 M USD | ||
| 3757 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.50 USD | +6.38% | -12.28% | -28.57% | +21.95% | 121.72 M USD | ||
| 3759 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 1.67 USD | -4.57% | -21.23% | -37.92% | -21.60% | 120.77 M USD | ||
| 3764 |  SPRB Spruce Biosciences, Inc. - Common Stock | 41.47 USD | +6.39% | -6.81% | -26.24% | -73.38% | 119.19 M USD | ||
| 3766 |  LFMD LifeMD, Inc. - Common Stock | 2.46 USD | +3.80% | -7.52% | -24.07% | -60.64% | 118.57 M USD | ||
| 3772 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 2.71 USD | +4.63% | -6.23% | -19.82% | +52.25% | 117.33 M USD | ||
| 3774 |  HURA TuHURA Biosciences, Inc. - Common Stock | 1.83 USD | +3.98% | -6.15% | -10.73% | -22.78% | 116.62 M USD | ||
| 3778 |  NERV Minerva Neurosciences, Inc - Common Stock | 2.42 USD | +2.98% | -25.08% | -32.02% | +0.41% | 115.55 M USD | ||
| 3780 |  CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 1.15 USD | +0.88% | -12.88% | -39.79% | +11.65% | 115.30 M USD |
뉴스 의료 관련 주식
UBS, 솔리드 바이오사이언스 투자의견 ‘매수’로 신규 개시···목표주가 20달러 제시
매크로제닉스, 진행성 고형암 환자 대상 비공개 표적 항체-약물 접합체 MGC030의 1상 임상시험에서 첫 환자 투여
목요일 장중 변동한 12개 헬스케어 주식
다이애딕 인터내셔널 13G 공시: 엠퍼리 에셋 매니지먼트, 9월 30일 기준 8.35% 지분 보유 보고
뉴라시스, 의료 정책 적용 범위가 2,600만 명 이상의 의료 보험 가입자에게 확대되었다고 발표
에데사 바이오테크, 백반증 치료제 EB06의 2상 임상시험을 위한 신약 임상시험계획(IND) 신청에 대해 FDA 승인 획득
렉사리아 바이오사이언스, 디하이드라테크-CBD 조성물 및 디하이드라테크-세마글루타이드 모두 평가한 동물실험 GLP-1-A26-1 결과 발표···아쉽게도 뇌 조직 내 DHT-SEMA 농도는 본 연구에 사용된 생물학적 분석의 정량 하한선 이하 수준
Gainers 의료 관련 주식
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Losers 의료 관련 주식
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |